NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Basilea Pharmaceutica AG (SW: BSLN)

 
BSLN Technical Analysis
5
As on 23rd Dec 2025 BSLN STOCK Price closed @ 55.20 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 45.93 & Strong Buy for SHORT-TERM with Stoploss of 41.04 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

BSLNSTOCK Price

Open 54.40 Change Price %
High 55.90 1 Day 0.70 1.28
Low 54.40 1 Week 1.80 3.37
Close 55.20 1 Month 9.85 21.72
Volume 38043 1 Year 13.80 33.33
52 Week High 58.60 | 52 Week Low 39.35
 
SW Switzerland Most Active Stocks
CSGN 0.82 0.00%
CSGN 0.82 0.00%
UBSG 36.94 0.44%
UBSG 36.94 0.44%
NOVN 110.10 1.27%
NOVN 110.10 1.27%
SIGN 10.97 5.08%
NESN 77.83 -0.26%
NESN 77.83 -0.26%
PRFN 0.03 50.00%
 
SW Switzerland Top Gainers Stocks
CADN 0.03 50.00%
PRFN 0.03 50.00%
PRFN 0.03 50.00%
ADXN 0.06 20.00%
ADXN 0.06 20.00%
BLS 0.13 18.18%
BLS 0.13 18.18%
BLS 0.13 18.18%
NEWN 0.94 17.50%
CIE 0.21 16.67%
 
SW Switzerland Top Losers Stocks
AFP 1.00 -93.75%
AFP 1.00 -93.75%
AFP 1.00 -93.75%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
 
 
BSLN
Daily Charts
BSLN
Intraday Charts
Whats New @
Bazaartrend
BSLN
Free Analysis
 
BSLN Important Levels Intraday
RESISTANCE58.09
RESISTANCE57.16
RESISTANCE56.59
RESISTANCE56.02
SUPPORT54.38
SUPPORT53.81
SUPPORT53.24
SUPPORT52.31
 
BSLN Forecast December 2025
4th UP Forecast67.63
3rd UP Forecast63.64
2nd UP Forecast61.18
1st UP Forecast58.72
1st DOWN Forecast51.68
2nd DOWN Forecast49.22
3rd DOWN Forecast46.76
4th DOWN Forecast42.77
 
BSLN Weekly Forecast
4th UP Forecast58.57
3rd UP Forecast57.49
2nd UP Forecast56.82
1st UP Forecast56.15
1st DOWN Forecast54.25
2nd DOWN Forecast53.58
3rd DOWN Forecast52.91
4th DOWN Forecast51.83
 
BSLN Forecast2025
4th UP Forecast97.98
3rd UP Forecast84.26
2nd UP Forecast75.78
1st UP Forecast67.3
1st DOWN Forecast43.1
2nd DOWN Forecast34.62
3rd DOWN Forecast26.14
4th DOWN Forecast12.42
 
 
BSLN Other Details
Segment EQ
Market Capital 500739264.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
BSLN Address
BSLN
 
BSLN Latest News
 
Your Comments and Response on Basilea Pharmaceutica AG
 
BSLN Business Profile
Basilea Pharmaceutica AG, a commercial stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. It offers Cresemba, an intravenous and oral azole antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, the European Union, and internationally, as well as in Phase III clinical trials for invasive fungal infections in Japan. The company also provides Zevtera, an antibiotic for the treatment of community and hospital-acquired pneumonia, as well as in Phase III clinical trials for the treatment of acute bacterial skin and skin structure infections, and Staphylococcus aureus bacteremia in European and various non-European countries. In addition, it engages in developing Derazantinib, a small molecule inhibitor, which is in phase 2 clinical trial for bile duct cancer, as well as in phase ½ clinical trial for bladder and stomach cancer; and Lisavanbulin, a tumor checkpoint controller drug. The company was founded in 2000 and is headquartered in Basel, Switzerland. Address: Grenzacherstrasse 487, Basel, Switzerland, 4058
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service